SK
Sri Kant Singh
About Sri Kant Singh
Data last updated:
Sri Kant Singh is a Director at Medieval Medical India Private Limited (since 2015), Ceo at Averco Global Private Limited (since 2025) and Director at Sripharma Lifesciences Private Limited (since 2023), and holds 3 more current directorships. The companies operate in Healthcare, Pharma and Water Treatment. The 4 current companies with reported revenue have a combined latest revenue of ₹12.20 Cr; the largest is Medieval Medical India Private Limited at ₹10.44 Cr (FY 2025). Earlier, Sri Kant Singh was a Director at Singh Modular Hospital Infra Private Limited (2024–2025) and Whole-Time Director at Medi Equip Services Private Limited (from 2017) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Sep 2015 | 2015 | ₹10.44 Cr (FY 2025) | Active | |
| Ceo | 01 Apr 2025 | 2022 | ₹1.12 Cr (FY 2025) | Active | |
| Director | 30 Dec 2023 | 2023 | ₹50.9 Lakh (FY 2025) | Active | |
| Director | 27 Dec 2023 | 2023 | ₹14.1 Lakh (FY 2025) | Active | |
| Director | 27 Jun 2025 | 2025 | Active | ||
| Director | 18 Feb 2015 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Jul 2024 | 2024 | ₹6.4 Lakh (FY 2025) | Active | |
| Whole-Time Director | 14 Jul 2017 | 2016 | Strike Off | ||
| Director | 19 Feb 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sri Kant Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pankaj Kumar Vyas | 07293161 | Medieval Medical India Private Limited | Director |
| Neeraj Gupta | 08229442 | Averco Global Private Limited | Director |
| Raman Deep Kaur | 07676458 | Averco Global Private Limited , Sripharma Lifesciences Private Limited and 3 more | Director |
| Ravi Kant Singh | 09174473 | Averco Global Private Limited , Sripharma Lifesciences Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sri Kant Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sri Kant Singh
Sri Kant Singh currently holds 6 directorships: Medieval Medical India Private Limited (Director, since 28 Sep 2015, revenue ₹10.44 Cr (FY 2025)); Averco Global Private Limited (Ceo, since 01 Apr 2025, revenue ₹1.12 Cr (FY 2025)); Sripharma Lifesciences Private Limited (Director, since 30 Dec 2023, revenue ₹50.9 Lakh (FY 2025)); Amexa Tech Services Private Limited (Director, since 27 Dec 2023, revenue ₹14.1 Lakh (FY 2025)); Plutark Meditech Private Limited (Director, since 27 Jun 2025); and 1 more.
Sri Kant Singh was first appointed on 18 Feb 2015 as Director at Sriarth Lifesciences Private Limited. The most recent appointment on record is 27 Jun 2025 at Plutark Meditech Private Limited.
The 4 current companies of Sri Kant Singh that report revenue have a combined latest revenue of ₹12.20 Cr: Medieval Medical India Private Limited ₹10.44 Cr (FY 2025); Averco Global Private Limited ₹1.12 Cr (FY 2025); Sripharma Lifesciences Private Limited ₹50.9 Lakh (FY 2025); Amexa Tech Services Private Limited ₹14.1 Lakh (FY 2025).
Sri Kant Singh held 3 earlier board appointments: Singh Modular Hospital Infra Private Limited (Director, 15 Jul 2024 to 23 Dec 2025); Medi Equip Services Private Limited (Whole-Time Director, from 14 Jul 2017); Sriarth Medical Services Private Limited (Director, from 19 Feb 2015).
The current boards of Sri Kant Singh's companies include Pankaj Kumar Vyas (Medieval Medical India Private Limited), Neeraj Gupta (Averco Global Private Limited), Raman Deep Kaur (Averco Global Private Limited), Ravi Kant Singh (Averco Global Private Limited).